South African pharmacy chain Dis-Chem Pharmacies reported a 9% increase in half-year earnings, driven by stronger retail sales and cost containment efforts, the company said in a trading update released on Thursday.
According to Reuters, Dis-Chem’s headline earnings per share, the main profit measure used in South Africa, rose to 91.2 cents for the six months ending August 2025, compared to 83.7 cents a year earlier. Revenue grew by 11 percent year on year, supported by higher sales volumes in health, beauty, and pharmaceutical products.
Chief Executive Rui Morais said in comments published by Bloomberg that the results reflect “solid operational execution and disciplined cost management despite persistent economic pressures.” He added that Dis-Chem would continue to expand its retail footprint while investing in digital health platforms to improve customer access.
Analysts cited by Business Insider Africa noted that the company’s performance underscores resilience in South Africa’s retail health sector, even amid reduced consumer spending power and rising logistics costs. Dis-Chem’s management said it remains optimistic about maintaining growth momentum into 2026, backed by sustained demand for healthcare and wellness products.
